Search
for
Sort by
Research 211–240 of 1000+
- New Modalities in the Treatment of Refractory Alopecia Areata
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- New and Emerging Therapies for Alopecia Areata
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- New Drugs for Alopecias
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Immune cell regulation of the hair cycle
- Integrated Transcriptomics and Metabolomics Analyses of Stress-Induced Murine Hair Follicle Growth Inhibition
- MiRNA-24 downregulates KLF6 affecting STAT3 protein expression and phosphorylation regulating melanogenesis in cashmere goat coat
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis